A carregar...
CMET-01. EFFICACY AND OUTCOME OF ANTI-PD1 THERAPY IN PATIENTS WITH LUNG CANCER BRAIN METASTASIS
BACKGROUND: There is very limited data on the benefit of checkpoint blockade in the lung cancer brain metastasis (LCBM). The only prospective data available is the study consisting of 18 patients with LCBM treated with pembrolizumab. We report our experience of 100 patients having LCBM treated with...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692816/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.151 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|